Insights from factor IX activation studies with chromogenic assays: implications of disparate product results
- PMID: 20561352
- DOI: 10.1111/j.1365-2516.2010.02300.x
Insights from factor IX activation studies with chromogenic assays: implications of disparate product results
Similar articles
-
A microtitre plate test for assessment of in-vitro thrombogenicity in factor IX concentrates using a chromogenic substrate.Thromb Res. 1989 Jan 15;53(2):191-6. doi: 10.1016/0049-3848(89)90379-4. Thromb Res. 1989. PMID: 2922707 No abstract available.
-
Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.Am J Vet Res. 1998 May;59(5):538-41. Am J Vet Res. 1998. PMID: 9582952
-
Monocyte procoagulant activity: development of a microtitre plate chromogenic assay.Br J Biomed Sci. 1994 Dec;51(4):328-31. Br J Biomed Sci. 1994. PMID: 7756938
-
Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.Semin Thromb Hemost. 2002 Jun;28(3):247-56. doi: 10.1055/s-2002-32658. Semin Thromb Hemost. 2002. PMID: 12098084 Review.
-
Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.Semin Thromb Hemost. 1983 Oct;9(4):281-300. Semin Thromb Hemost. 1983. PMID: 6362011 Review. No abstract available.
Cited by
-
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec.Thromb Haemost. 2024 Oct;124(10):912-921. doi: 10.1055/s-0044-1787734. Epub 2024 Jun 11. Thromb Haemost. 2024. PMID: 38863155 Free PMC article. Clinical Trial.
-
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.Haematologica. 2018 Apr;103(4):e181-e183. doi: 10.3324/haematol.2017.185330. Epub 2018 Feb 22. Haematologica. 2018. PMID: 29472355 Free PMC article. No abstract available.
-
Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples.Int J Lab Hematol. 2020 Jun;42(3):350-358. doi: 10.1111/ijlh.13189. Epub 2020 Mar 23. Int J Lab Hematol. 2020. PMID: 32202380 Free PMC article.
-
Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity.Thromb Haemost. 2014 Nov;112(5):932-40. doi: 10.1160/TH13-11-0971. Epub 2014 Aug 21. Thromb Haemost. 2014. PMID: 25144892 Free PMC article.
-
Activity measurements of dalcinonacog alfa.Haemophilia. 2020 Mar;26(2):346-353. doi: 10.1111/hae.13949. Epub 2020 Mar 6. Haemophilia. 2020. PMID: 32142203 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources